<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Posts on Jeffrey A. Walker</title>
    <link>/post/</link>
    <description>Recent content in Posts on Jeffrey A. Walker</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2018</copyright>
    <lastBuildDate>Mon, 07 May 2018 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="/post/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Some Intuition Behind Hierarchical Modeling</title>
      <link>/post/some-intuition-behind-hierarchical-modeling/</link>
      <pubDate>Mon, 07 May 2018 00:00:00 +0000</pubDate>
      
      <guid>/post/some-intuition-behind-hierarchical-modeling/</guid>
      <description>This is an archive of an external source
Hierarchical modeling is a powerful tool for making inferences about multiple groups in clinical trials, whether these groups are multiple indications or tumor types in an oncology study, multiple sites in a device clinical trial, or any other source of patient heterogeneity.
Hierarchical models that share information across groups form a backbone of modern Bayesian thinking. We currently employ hierarchical modeling most commonly in our oncology basket trials, see for example Berry et.</description>
    </item>
    
  </channel>
</rss>